Healthcare resource usage of schizophrenia patients initiating long-acting injectable antipsychotics vs oral
Authors:
- 29 October 2012
- journal article
- Published by Informa Healthcare in Journal of Medical Economics
- Vol. 16 (2) , 231-239
Abstract
Objective:To compare hospitalizations and incidence of relapses among patients with schizophrenia initiating long-acting injectable (LAI) antipsychotics vs oral antipsychotics.Methods:Patients with schizophrenia initiating LAI antipsychotics or oral antipsychotics (index events) were identified from large databases (MarketScan; Truven Health Analytics, CA), containing commercial and Medicare healthcare claims and their pre-index (12-month baseline period) and post-index (12-month follow-up period) hospitalizations and relapse rates were compared. Descriptive and bivariate statistics were utilized to compare demographics, clinical characteristics, and hospital resource usage among cohorts. Multivariate analysis was used to evaluate the impact of initiating LAI vs oral antipsychotics on differences in the number of hospitalizations and length of stay (LOS) between follow-up and baseline periods.Results:Commercially insured patients initiating LAI antipsychotics (n = 394) had significant reductions i...Keywords
This publication has 21 references indexed in Scilit:
- Resource utilization in patients with schizophrenia who initiated risperidone long-acting therapy: results from the Schizophrenia Outcomes Utilization Relapse and Clinical Evaluation (SOURCE)BMC Psychiatry, 2011
- Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and BelgiumAnnals of General Psychiatry, 2011
- Evaluation of health services use following the initiation of risperidone long-acting therapy among schizophrenia patients in the veterans health administrationJournal of Clinical Pharmacy and Therapeutics, 2010
- Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United StatesCurrent Medical Research and Opinion, 2007
- The Economic Burden of Schizophrenia in the United States in 2002The Journal of Clinical Psychiatry, 2005
- A Systematic Review of the Prevalence of SchizophreniaPLOS Medicine, 2005
- Patterns and Quality of Treatment for Patients With Schizophrenia in Routine Psychiatric PracticePsychiatric Services, 2005
- A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodologyBMC Medicine, 2004
- Prevalence of and Risk Factors for Medication Nonadherence in Patients With SchizophreniaThe Journal of Clinical Psychiatry, 2002
- Systematic meta-review of depot antipsychotic drugs for people with schizophreniaThe British Journal of Psychiatry, 2001